Sensitivity to mivacurium in a patient with mitochondrial myopathy

Anesthesiology

Volumn 84, Issue 6, 1996, Pages 1506-1509

  Naguib, Mohamed ^a,b   El Dawlatly, Abdel Azim ^a   Ashour, Mahmoud ^a   Al Bunyan, Muneera ^a  

^a Department of Anaesthesia ^*

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Antagonists, neuromuscular relaxants: edrophonium; Complications: mitochondrial myopathy; Monitoring: train of four; Neuromuscular relaxants: mivacurium chloride

Indexed keywords

MIVACURIUM;

ARTICLE; CASE REPORT; CHILD; DEPOLARIZATION; DRUG SENSITIVITY; HUMAN; MALE; MELAS SYNDROME; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; NERVE BLOCK; NERVE CONDUCTION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADOLESCENT; ANESTHESIA; HUMANS; ISOQUINOLINES; MALE; MITOCHONDRIAL MYOPATHIES; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 0029977467     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199606000-00029     Document Type: Article

References (23)

1. Morgan-Hughes JA: Mitochondrial diseases, Skeletal Muscle Pathology. Edited by Mastaglia FL, Walton J. Edinburgh, Churchill Livingstone, 1992, pp 367-424
2. Olson W, Engel WK, Walsh GO, Einaugler R: Oculocraniosomatic neuromuscular disease with 'ragged-red' fibres. Arch Neurol 1972; 26:193-211
3. Kearns TP, Sayre GP: Retinitis pigmentosa, external ophthalmoplegia, and complete heart block: Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 1958; 60:280-9
4. Pavlakis S, Phillips PC, DiMauro S, De Vivo DC, Rowland LP: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Ann Neurol 1984; 16:481-8
5. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T: Myoclonous epilepsy associated with ragged-red fibres (mitochondrial abnormalities): Disease entity or a syndrome? Light- and electron-microscopic studies of two cases and review of the literature. J Neurol Sci 1980; 47:117-33
6. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE, Threlkeld AB, Mitsumoto H, Salberg LM, Rowland LP, DiMauro S: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44:721-7
7. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. AmJ Hum Genet 1990; 46:428-33
8. James RH: Thiopentone and ophthalmoplegia plus (letter). Anaesthesia 1985; 40:88
9. Roberts NK, Perloff JK, Kark RAP: Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy): Report of 2 cases and review of 17 published cases. Am J Cardiol 1979; 44:1396-400
10. Maslow A, Lisbon A: Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg 1993; 76:884-6
11. Robertson JA: Ocular muscular dystrophy: A cause of curare sensitivity. Anaesthesia 1984; 39:251-3
12. Jacob JC, Varkey GP: Curare sensitivity in ocular myopathy. Can Anaesth Soc J 1966; 13:449-52
13. Lessell S, Kuwabara T, Feldman RG: Myopathy and succinylcholine sensitivity. Am J Ophthalmol 1969; 68:789-96
14. D'Ambra MN, Dedrick D, Savarese JJ: Kearns-Sayre syndrome and pancuronium-succinylcholine-induced neuromuscular blockade. ANESTHESIOLOGY 1979; 51:343-5
15. Paterson IG, Hood JR, Russell SH, Weston MD, Hirsch NP: Mivacurium in the myasthenic patient. Br J Anaesth 1994; 73:494-8
16. Naguib M, El-Gammal M, Daoud W, Ammar A, Moukhtar H, Turkistani A: Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. ANESTHESIOLOGY 1995; 82:1288-92
17. Hart PS, Wright PMC, Brown R, Lau M, Sharma ML, Miller RD, Gruenke L, Fisher DM: Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. ANESTHESIOLOGY 1995; 82:912-8
18. Calvey TN, Williams NE, Muir KT, Barber HE: Plasma concentration of edrophonium in man. Clin Pharmacol Ther 1976; 19:813-20
19. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA: The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short-acting nondepolarizing ester neuromuscular blocking drug. ANESTHESIOLOGY 1988; 68:723-32
20. Gitlin MC, Jahr JS, Margolis MA, McCain J: Is mivacurium chloride effective in electroconvulsive therapy?: A report of four cases, including a patient with myasthenia gravis. Anesth Analg 1993; 77: 392-4
21. Ohtani Y, Miike T, Ishitsu T, Matsuda I, Tamari H: A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7:249
22. Felipe MAN, Gottmann S, Khambatta HJ: Malignant Hyperthermia Current Concepts. Madrid, Normed, 1988, pp 11-8
23. Carroll JE, Zwillich C, Weil JV, Brooke MH: Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 1976; 26:140-6